Kickstart Your UK Pharma Funding Journey with Clarity
Funding a pharma or biotech venture in the UK can feel like navigating a maze. Grants, tax reliefs, investor pitches—there’s a lot to juggle. But proper planning around the Seed Enterprise Investment Scheme (SEIS) and the Enterprise Investment Scheme (EIS) can transform complexity into opportunity. Here, we break down the essentials and share practical steps to secure the backing your science-driven startup needs.
No more guesswork. Align your financial road map with the right schemes, understand compliance hurdles, and attract the right angel investors. If you’re ready to work with startup investment experts, discover tailored, commission-free guidance and commission-free access through Revolutionizing Investment Opportunities in the UK with startup investment experts.
Why SEIS and EIS Matter for Pharma and Biotech Startups
Pharma and biotech innovation is expensive, slow and heavily regulated. The right funding channels can make or break early-stage companies.
- SEIS offers up to 50% income tax relief and exemption from capital gains tax on gains reinvested into your startup.
- EIS extends relief up to 30% for larger raises, plus deferral of certain capital gains and loss relief.
- Both schemes increase investor confidence, making your pitch more compelling to early backers.
By structuring your rounds around SEIS and EIS, you tap into a pool of investors seeking tax-efficient opportunities and accelerate your path to critical milestones.
Understanding SEIS: The First Stepping Stone
The Seed Enterprise Investment Scheme is built for startups in their very first seed round. Key points:
- Eligible companies must be under two years old.
- Qualifying trades exclude property development and financial services.
- Maximum of £150,000 can be raised under SEIS.
- Investors get up to 50% income tax relief on investments up to £100,000 per tax year.
- Capital gains reinvested into SEIS shares can be exempt.
Practical tip: align your milestone timetable to fit the two-year window and secure your SEIS Advance Assurance early.
Understanding EIS: Scale with Confidence
As you graduate past the seed phase, EIS lets you raise up to £5 million per year (and a maximum of £12 million over your lifetime).
- Investors receive 30% income tax relief.
- Deferral of capital gains tax on assets sold before investment.
- Loss relief and inheritance tax relief may apply.
- Companies must have carried on a qualifying trade for at least two years.
EIS is perfect when you need a larger cash injection to fund clinical trials, regulatory submissions or scale manufacturing.
Blending SEIS and EIS in a Cohesive Strategy
Rather than treating SEIS and EIS as isolated tactics, blend them into a staged roadmap:
- Start with SEIS to attract small-scale angels keen on high-risk, high-reward science.
- After two years and initial validation, transition the same investors or new backers into an EIS round.
- Structure share classes to maintain control while offering compelling terms.
- Plan your fundraising announcements to align with major scientific or regulatory milestones.
This seamless flow helps you maintain momentum, keep existing investors engaged and secure the right funding at each phase.
How Oriel IPO Supports Your Funding Effort
Navigating SEIS/EIS rules can be daunting, but Oriel IPO brings clarity and efficiency. As a UK-based commission-free investment marketplace, Oriel IPO helps you:
- Showcase your vetted opportunity in front of active angel investors.
- Keep 100% of the funds you raise, thanks to a transparent subscription model.
- Access curated resources: detailed guides, webinars and templates tailored to SEIS/EIS complexities.
- Benefit from a streamlined process, where compliance checks and investor accreditation happen in one place.
If you want to team up with startup investment experts who understand the biotech sector, Work with startup investment experts to explore commission-free funding opportunities.
Tips for a Strong SEIS/EIS Application
Your application needs precision. Here’s how to stand out:
- Craft a crystal-clear business model based on scientific proof of concept.
- Develop robust financial projections that show break-even points and cash burn.
- Map out a regulatory pathway: MHRA approvals, clinical trial phases, patents.
- Prepare thorough documentation: Articles of association, valuation reports and investor decks.
- Engage a qualified adviser for SEIS/EIS Advance Assurance before you pitch.
By ticking these boxes, you reassure both HMRC and investors that you’re a safe bet.
The Essential Role of Accountants and Advisers
Accountants and tax advisers play a vital part in your SEIS/EIS success. They can:
- Advise on qualifying expenses and share structures.
- Coordinate with HMRC for timely EIS3 and SEIS3 certification.
- Guide investors through relief claims and compliance.
- Support ongoing reporting to maintain good standing.
Partnering with startup investment experts and your advisory team ensures you avoid common pitfalls, reduce delays and build trust with backers.
Testimonials
“Working with Oriel IPO completely changed our fundraising approach. We secured SEIS backing in weeks, not months. Their platform’s clarity saved us time so we could focus on R&D.”
— Dr Elaine Baker, CEO, BioNova Therapeutics
“Oriel IPO’s commission-free model meant every pound we raised went straight into cell-line optimisation. The EIS guidance was spot on.”
— James Wilson, Co-founder, NeuraHeal Ltd
“As someone new to SEIS/EIS, I valued the step-by-step guides and expert webinars. The investor network they opened gave us our first major round.”
— Dr Priya Singh, CTO, OncoTech Pharma
Staying Ahead: Next Steps for Your Pharma-Biotech Startup
You’ve got the basics. Now:
- Finalise your pitch deck with clear timelines and scientific validation.
- Lock in your SEIS Advance Assurance—don’t leave it to the last minute.
- Plan your EIS strategy early so you can scale without a funding gap.
- Leverage Oriel IPO’s educational webinars to brush up on compliance changes.
- Keep communication lines open with angel syndicates and professional advisers.
Your path to growth is paved with planning, partnerships and the right funding strategy.
In the world of high-risk, high-reward innovation, collaborating with startup investment experts can be the tipping point. Connect with startup investment experts to kickstart your SEIS/EIS journey
